SCHEMBL8962533

SCHEMBL8962533

CC(C)c1cccc(C(C)C)c1NS(=O)(=O)C(C(O)=S)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.39
SOAT1 P35610 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8962989 0.87 KMT2A (0.48) KMT2ALMNAMEN1
SCHEMBL8962450 0.76 SRC (0.45) SOAT1
SCHEMBL8962444 0.74 SOAT2 (0.41) KMT2ALMNASOAT1
SCHEMBL8962536 0.72 SOAT1 (0.44) KMT2ALMNASOAT1
SCHEMBL8962537 0.72 LMNA (0.46) KMT2ALMNA
SCHEMBL9391001 0.70 LMNA (0.44) KMT2ALMNA
SCHEMBL11234113 0.69 L3MBTL1 (0.63) KMT2ALMNAL3MBTL1
SCHEMBL8962517 0.69 KMT2A (0.40) KMT2ALMNAMEN1SOAT1
SCHEMBL7567348 0.69
SCHEMBL7082105 0.68 NLRP3 (0.50) KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491170-A TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-02-13 US disclosed